Advocate Illinois Masonic Med is categorized under Drug Abuse and Addiction Treatment in Chicago, IL .
Advocate Illinois Masonic Med was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Drug Abuse and Addiction Treatment business, which does work in the B2C market, and is classified as a Drug Abuse and Addiction Treatment, under code number 8133190 by the NAICS.
If you are seeking more information, feel free to contact Carroll Cradock, Executive Director at the company’s single location by writing to 938 West Nelson St, Chicago, Illinois IL 60657 or by phoning (773) 769-6200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Advocate Illinois Masonic Med |
Contact Person: | Carroll Cradock, Executive Director |
Address: | 938 West Nelson St, Chicago, Illinois 60657 |
Phone Number: | (773) 769-6200 |
Annual Revenue (USD): | Unknown |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Drug Abuse and Addiction Treatment |
SIC Code: | 8399 |
NAICS Code: | 8133190 |
Share This Business: |
Advocate Illinois Masonic Med was started in 0 to provide professional Drug Abuse and Addiction Treatment under the SIC code 8399 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Carroll Cradock, Executive Director for inquiries that concern Advocate Illinois Masonic Med by calling the company number (773) 769-6200, as your correspondence is most welcome. Additionally, the physical location of the single location of Advocate Illinois Masonic Med can be found at the coordinates 41.93723,-87.65313 as well as the street address 938 West Nelson St in Chicago, Illinois 60657.
For its online presence, you may visit Advocate Illinois Masonic Med’s website at and engage with its social media outlets through on Twitter and on Facebook.